Instil Bio appoints Tim Moore as COO

Sep. 06, 2022 7:13 AM ETInstil Bio, Inc. (TIL)By: Meghavi Singh, SA News Editor
  • Instil Bio (NASDAQ:TIL) has appointed Tim Moore to the role of COO.
  • Mr. Moore most recently served as the President and COO of PACT Pharma, a cell therapy company focusing on neo-antigen directed TCR-T cell therapy.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.